It is a pharma private limited company based in Solapur, Maharashtra, India, established in 2016.
2016 | Solapur, Maharashtra, India | ActiveBrightway Pharmaceuticals Private Limited, a active private limited company, was established on 19 October 2016 in Solapur, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999PN2016PTC166851. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Akbar Abdul Gani Loni (Director), Sirajoddin Abdulgafoor Shaikh (Director). Past directors included Mahiboob Siddakaji Hannure, Abduljalil Babulal Loni, Rahim Khunmeer Langde. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Shop No. 7, Square One Com, 131 Sidheshwar Peth Gr Fl Solapur 413003, Solapur, Maharashtra, 413003.
U74999PN2016PTC166851
166851
19 October 2016
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Brightway Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akbar Abdul Gani Loni | Director | 19 Oct 2016 | Current |
| Sirajoddin Abdulgafoor Shaikh | Director | 07 Aug 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 01 Dec 2021 | Past |
| Pramod Abcsdd | Director | 07 Aug 2017 | Past |
| Pramod Abcsdd | Director | 07 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Brightway Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 524.25% increase. The company also saw a substantial fall in profitability, with a 223.13% decrease in profit. The company's net worth Soared by an impressive increase of 189.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Brightway Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Brightway Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Brightway Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brightway Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Brightway Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Brightway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune. was recorded as a recent event.
The activity Sirajoddin Abdulgafoor Shaikh was appointed as a Director was appointed as a Director on 07 Aug 2017 & has been associated with this company since 8 years 4 months . was completed.
Akbar Abdul Gani Loni was appointed as a Director was appointed as a Director on 19 Oct 2016 & has been associated with this company since 9 years 2 months . was recorded as a recent event.
Brightway Pharmaceuticals Private Limited was registered on 19 Oct 2016 with Roc Pune & aged 9 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Brightway Pharmaceuticals Private Limited is U74999PN2016PTC166851.
Brightway Pharmaceuticals Private Limited is headquartered at Shop No. 7, Square One Com, 131 Sidheshwar Peth Gr Fl Solapur 413003, Solapur, Maharashtra, 413003.
Brightway Pharmaceuticals Private Limited was incorporated on 19 October 2016.
The current directors of Brightway Pharmaceuticals Private Limited are
The primary industry of Brightway Pharmaceuticals Private Limited is Manufacturing.
Brightway Pharmaceuticals Private Limited is unlisted.
The authorized capital of Brightway Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Brightway Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX